Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Trinitan Metals and Minerals Tbk. (PURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Trinitan Metals and Minerals Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Trinitan Metals and Minerals Tbk. trades at Rp51 (market cap 70.13B). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.4× Trinitan Metals and Minerals Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | PURE | |
|---|---|---|
Market Cap | 166.01B | 70.13B |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Trinitan Metals and Minerals Tbk.
PT Trinitan Metals and Minerals Tbk (the Entity) was established based on Notarial Deed No. 14, dated June 9, 2009, of Petrus Suandi Halim, S.H., notary in Jakarta. The Entity started its commercial operations in 2011. The Entity belong to group of companies owned by Trinitan Group. The Entity's parent entity is PT Trinitan Resourcetama Indonesia.
Read more on PURE →
